Pertuzumab and Trastuzumab deruxtecan
About
Membership operator: AND
Therapies: 2
Therapies
Pertuzumab (tx:ncit:C38692)
Trastuzumab deruxtecan (tx:ncit:C128799)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | HER2-positive | Invasive Breast Carcinoma | Pertuzumab, Trastuzumab deruxtecan |